Larissa Kopp
Fraunhofer Society
1 Papers
2 Citations
Larissa Kopp is an academic researcher from Fraunhofer Society. The author has contributed to research in topics: IκB kinase & Cell adhesion molecule. The author has co-authored 1 publications.
Chat about Author
Papers
Xenocoumacin 2 reduces protein biosynthesis and inhibits inflammatory and angiogenesis-related processes in endothelial cells
Pelin Erkoc,Michaela Schmitt,Rebecca Ingelfinger,Iris Bischoff-Kont,Larissa Kopp,Helge B. Bode,Susanne Schiffmann,Robert Fürst +7 more
TL;DR: Xenocoumacin (Xcn) 1 and 2 are the major antibiotics produced by the insect-pathogenic bacterium Xenorhabdus nematophila.
2